Ads
related to: chemotherapy drugs for breast cancer- Overall Survival Results
See Updated Overall Survival Data
For This Treatment Option
- Dosing & Administration
Read More About Dosing
And How To Prescribe
- Financial Resources
Learn About The Available Access
Programs For Your Patients
- Official Video Library
See A Medical Expert Discuss
Overall Survival Data For mBC
- Patient Support
View The The Service Request Form
To Gain Access To Support Programs
- Safety Profile
View The Full Safety Profile And
See Side Effects For This Option
- Overall Survival Results
Search results
Merck's Multi-Billion Cancer Drug Keytruda Aces Late-Stage Breast Cancer Study (UPDATED)
Benzinga via Yahoo Finance· 6 hours agoTuesday, Merck & Co Inc (NYSE:MRK) released topline data from hase 3 KEYNOTE-522 trial of Keytruda...
Scientists create tailored drug for aggressive breast cancer
Medical Xpress· 7 days agoThe research, published in Clinical Cancer Research by a team from King's College London...method in...
PKMYT1, a potential 'Achilles heel' of treatment resistant ER+ breast cancers with the poorest...
Medical Xpress· 4 days agoSpecifically, they searched for enzymes called kinases, whose expression is typically altered in ...
New customised drug developed to fight aggressive breast cancer
Investing.com· 7 days agoNew customised drug developed to fight aggressive breast cancer
Docs support drug regulator’s move to withdraw Olaparib for some cancer patients
Investing.com· 6 days agoDrug Controller General of India's (DCGI) mandate to state authorities to withdraw AstraZeneca’s...
Those lost to Agent Orange, Camp Lejeune exposure honored in Peabody
The Salem News· 16 hours agoFour months later, she was diagnosed with stage-one breast cancer. Ramos underwent radiation and a...
Inhibition of lysosomal TRPML1 channel eliminates breast cancer stem cells by triggering ferroptosis...
Nature· 2 days agoPharmacological inhibition and genetic depletion of TRPML1 promote ferroptosis in breast CSCs, reduce their stemness, and enhance the sensitivity of breast
AstraZeneca-Daiichi's Enhertu follow-up unable to prove overall survival benefit in phase 3
FierceBiotech· 13 hours agoDaiichi Sankyo and antibody-drug conjugate (ADC) partner AstraZeneca have already filed their...
Targeting 'monster cancer cells' could reduce recurrence rates after cancer therapy
Medical Xpress· 4 hours agoBoth types of therapy put cancer cells under stress, with the goal of causing them to self-destruct. Recently, scientists have begun to look at the role of polyploid giant ...
Roche’s Sabry retires; Duchenne drug fails confirmatory test
BioPharma Dive via Yahoo Finance· 13 hours agoThe veteran executive will be replaced by Boris Zaïtra. Elsewhere, Nippon Shinyaku shared negative...